| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |